Estudio clínico del tratamiento de la queratoconjuntivitis seca con ciclosporina A

Se ha realizado un estudio clínico de la aplicación de ciclosporina en colirio al 2% durante dos años y medio, sobre 48 animales afectados de queratoconjuntivitis seca. Los resultados obtenidos se han visto ligados a diferentes factores como son: el valor inicial del test de Schirmer, el estado de la córnea y la etiología y evolución del proceso. En todo caso, su aplicación aumenta la producción de lágrimas de forma significativa y/o proporciona aumento del bienestar ocular por la disminución de la inflamación local, permitiendo eliminar o disminuir la administración concomitante de sustitutos de lágrimas.We have performed a 2 years long clinical study on 2% cyclosporine collyre administration on 48 dogs suffering from keratoconjunctivitis sicca. Results are influenced by several factors, as Schirmer test initial values, corneal status, and the etiology and evolution of the disease. Anyway, 2% cyclosporine collyre administration significantly in creases tear secretion and/or benefits ocular status by reducing local inflamation, thus allowing to diminish or eliminate administration of tear substitutes

Displasia de cadera en el perro : estado actual

La displasia de cadera en el perro es una patología que se presenta con relativa frecuencia en la clínica de pequeños animales. Si bien su diagnóstico es sencillo cuando la lesión ya se encuentra en una fase avanzada, en ocasiones no lo es tanto cuando aquélla se encuentra en una fase inicial en la que tanto los signos clínicos como los radiológicos no son demasiado evidentes. La importancia de realizar un diagnóstico precoz, así como la elección de la técnica quirúrgica más adecuada en cada caso, son aspectos fundamentales para poder asegurar el mejor pronóstico. En el presente trabajo se repasan los distintos aspectos de la enfermedad.Canine hip dysplasia is a relatively common problem in small animal practice. Although its diagnosis is easy in an advanced stage, it becomes harder in earlier stages when clinical signs and radiological features are not so evident. The early diagnosis, as well as the most convenient surgical technique selection, are the key points to ensure the best prognosis. This paper reviews the different aspects of hip dysplasia

Medicina de familia como asignatura obligatoria en el grado de Medicina de la Universitat de Lleida: análisis de la percepción de los estudiantes

Evaluar la percepción y la satisfacción respecto a la adquisición de competencias sobre la especialidad de Medicina de Familia y Comunitaria (MFyC) por parte de los estudiantes de pregrado matriculados en el primer año de instauración de la asignatura obligatoria de nuestra especialidad en la Facultad de Medicina de la Universitat de Lleida

Association of MC1R Variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study

<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma. Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and some variants of the melanocortin-1 receptor gene (MC1R), which is known to have a role in the pigmentation process. However, investigation of the associations of both MC1R variants and host phenotypes with melanoma risk has been limited.</p> <p><b>Methods</b> We included 815 CDKN2A mutation carriers (473 affected, and 342 unaffected, with melanoma) from 186 families from 15 centers in Europe, North America, and Australia who participated in the Melanoma Genetics Consortium. In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, ≥2 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers. These associations were estimated and tested using generalized estimating equations. All statistical tests were two-sided.</p> <p><b>Results</b> Carrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 × 10−6 ≤ P ≤ .0007). A consistent pattern of increase in melanoma risk was also associated with increase in number of MC1R variants. The risk of melanoma associated with at least two MC1R variants was 2.6-fold higher than the risk associated with only one variant (odds ratio = 5.83 [95% confidence interval = 3.60 to 9.46] vs 2.25 [95% confidence interval = 1.44 to 3.52]; Ptrend = 1.86 × 10−8). The joint analysis of MC1R variants and host phenotypes showed statistically significant associations of melanoma risk, together with MC1R variants (.0001 ≤ P ≤ .04), hair color (.006 ≤ P ≤ .06), and number of nevi (6.9 × 10−6 ≤ P ≤ .02).</p> <p><b>Conclusion</b> Results show that MC1R variants, hair color, and number of nevi were jointly associated with melanoma risk in CDKN2A mutation carriers. This joint association may have important consequences for risk assessments in familial settings.</p&gt

Extinction of a Pavlovian-conditioned inhibitor leads to stimulus-specific inhibition

Conditioned inhibitors have been shown to be largely unaffected by non-reinforced exposure (i.e., extinction treatment). Although excitatory associations are readily diminished by extinction treatment, so-called inhibitory associations appear to be largely immune to them. In two fear conditioning experiments with rats, it was found that a decrease in inhibitory control can result from a massive number of extinction exposures to the inhibitor. Experiment 1 provided evidence that extinction treatment attenuated negative summation between the potential inhibitor and a transfer excitor. However, the extinction treatment had no influence on responding to the original training compound, indicating that some stimulus-specific inhibitory potential remained even after massive extinction. Experiment 2 indicated that retarded excitatory acquisition to the inhibitory stimulus observed after extinction treatment of the inhibitor is no greater than that following a similar amount of stimulus pre-exposure without prior inhibition training (i.e., latent inhibition). The findings indicate that inhibitory associations can be extinguished with large numbers of extinction trials, but they appear to be much more resistant to extinction than excitatory associations

Hexaaqua­cobalt(II) 4,4′-(1,2-dihy­droxy­ethane-1,2-di­yl)dibenzoate monohydrate

The title compound, [Co(H2O)6](C16H12O6)·H2O, is composed of one 4,4′-(1,2-dihy­droxy­ethane-1,2-di­yl)dibenzoate anion lying on an inversion center, one [Co(H2O)6]2+ dicationic complex and a solvent water mol­ecule located on mirror planes. In the crystal, a chain is constructed via O—H⋯O hydrogen bonds involving the carboxyl­ate and hydroxyl groups of the organic anion; the chains are further connected into a three-dimensional framework by additional O—H⋯O hydrogen bonds between the [Co(H2O)6]2+ cations, solvent water mol­ecules and the anions

T-Type Calcium Channels: A Potential Novel Target in Melanoma

T-type calcium channels (TTCCs) are overexpressed in several cancers. In this review, we summarize the recent advances and new insights into TTCC biology, tumor progression, and prognosis biomarker and therapeutic potential in the melanoma field. We describe a novel correlation between the Cav3.1 isoform and the increased basal autophagy in BRAFV600E-mutant melanomas and after acquired resistance to BRAF inhibitors. Indeed, TTCC blockers reduce melanoma cell viability and migration/invasion in vitro and tumor growth in mice xenografts in both BRAF-inhibitor-sensitive and -resistant scenarios. These studies open a new, promising therapeutic approach for disseminated melanoma and improved treatment in BRAFi relapsed melanomas, but further validation and clinical trials are needed for it to become a real therapeutic optionThis work was supported by grants from ISCIII/FEDER “Una manera de hacer Europa” (PI1500711 to RMM; PI18/00573 to RMM and AM). CB and PS hold a pre-doctoral fellowship from UdL-IRBLleida. RI holds a pre-doctoral fellowship from Asociación Española Contra el Cancer (AECC), Catalunya Contra el Cancer, Lleida. AM holds a post-doctoral fellowship from Asociación Española Contra el Cancer (AECC)

Nutrición enteral domiciliaria en España: registro Nadya del año 2011-2012

Objective: To describe the results of the home enteral nutrition (HEN) registry of the NADYA-SENPE group in 2011 and 2012. Material and methods: We retrieved the data of the patients recorded from January 1st 2011 to December 31st 2012. Results: There were 3021 patients in the registry during the period from 29 hospitals, which gives 65.39 per million inhabitants. 97.95% were adults, 51.4% male. Mean age was 67.64 ± 19.1, median age was 72 years for adults and 7 months for children. Median duration with HEN was 351 days and for 97.5% was their first event with HEN. Most patients had HEN because of neurological disease (57.8%). Access route was nasogastric tube for 43.5% and gastrostomy for 33.5%. Most patients had limited activity level and, concerning autonomy, 54.8% needed total help. Nutritional formula was supplied from chemist’s office to 73.8% of patients and disposables, when necessary, was supplied from hospitals to 53.8% of patients. HEN was finished for 1,031 patients (34.1%) during the period of study, 56.6% due to decease and 22.2% due to recovery of oral intake. Conclusions: Data from NADYA-SENPE registry must be explained cautiously because it is a non-compulsory registry. In spite of the change in the methodology of the registry in 2010, tendencies regarding HEN have been maintained, other than oral routeObjetivos: Describir los resultados del registro de nutrición enteral domiciliaria (NED) del grupo NADYASENPE de los años 2011 y 12. Material y métodos: Se recopilaron los datos introducidos en el registro desde el 1 de enero de 2011 al 31 de diciembre de 2012. Resultados: Hubo 3021 pacientes en el registro durante el periodo, procedentes de 29 hospitales, lo que da una prevalencia de 65,39 casos por millón de habitantes. 97.95% fueron adultos, 51,4% varones. La edad media fue 67,64 ± 19,1 años y la mediana 72 años para los adultos y 7 meses para los niños. La duración media de la NED fue 351 días y para el 97,5% fue el primer episodio con NED. La mayoría de pacientes tenían NED por una enfermedad neurológica (57,8%). La vía de acceso fue sonda nasogástrica para el 43,5% y gastrostomía para el 33,5%. La mayoría de pacientes tuvieron un nivel de actividad física limitado y, respecto a la autonomía, 54,8% necesitaba ayuda total. La fórmula de nutrición se suministró desde las oficinas de farmacia para el 73,8% y los fungibles, cuando fueron necesarios, desde los hospitales para el 53,8%. La NED se suspendió en 1.031 pacientes (34,1%) durante el periodo de estudio, 56,6% debido a fallecimiento y 22,2% debido a recuperación de la vía oral. Conclusiones: Los datos del registro NADYA-SENPE deben ser interpretados con precaución ya que se trata de un registro voluntario. A pesar del cambio de metodología del registro en 2010, las tendencias en NED se han mantenido, salvo la importancia cuantitativa de la vía ora